Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/2/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. John L. Kolman

Wrong Dr. John L. Kolman?

Executive Director and Head of Tr...

QPS Holdings LLC
Phone: (302) ***-****  
Email: j***@***.com
Local Address:  Philadelphia , Pennsylvania , United States
QPS, LLC
1 Innovation Way, Suite 200
Newark , Delaware 19711
United States

Company Description: Clinical trials keep pharmaceuticals safe and effective. QPS Bio-Kinetic has conducted clinical studies for over 15 years, with more than 20,000 participants.
Background

Employment History

Education

  • PhD , Molecular Biophysics and Biochemistry
    Yale University
  • undergraduate degree cum laude , Honors Biology and Chemistry
    University of Illinois
  • Master's degree , Molecular Biophysics and Biochemistry
    Yale University
23 Total References
Web References
:: BioReliance ::
www.bioreliance.com, 13 Feb 2007 [cached]
BioReliance Corporation announced today that John L. Kolman, PhD, has been named Senior Director, Research and Development.
Speaker/Bios « 2011 PDA Annual Meeting
pdaannualmeeting.org, 25 April 2011 [cached]
John Kolman
...
John Kolman
BioReliance
Dr. Kolman joined BioReliance in April of 2008 as head of the newly formed Global Research and Development as well as the Department of Genomics. Prior to that, he was a Principal Scientist in the Corporate Research Laboratory of Invitrogen Corp. There, he built collaborations with academic thought leaders and led cross-department teams in the application of cutting edge technologies to novel, high-impact areas.
John received his Ph.D from Yale University for the study of molecular events underpinning Epstein-Barr virus lytic activation. He then continued with a post-doctoral appointment at the Salk Institute, eventually rising to Staff Scientist. His career has been motivated by the study of difficult biological questions using new molecular approaches.
QPS Announces John ...
www.qps.com, 30 May 2015 [cached]
QPS Announces John Kolman as Executive Director and Head of Translational Medicine - November, 2014 The Big Picture: Why We Do What We Do - Antibody-Drug Conjugates (ADCs) in Action - November, 2014
...
John L Kolman
...
John L Kolman Executive Director and Head of Translational Medicine
...
John L Kolman
...
John L Kolman, Ph.D. Executive Director and Head of Translational Medicine
John joined QPS, LLC in 2014 to lead the Translational Medicine unit. He has twenty years' experience designing assays and supporting clinical trial testing in regulated laboratory environments. Previous leadership roles include Head of Genomics for BioReliance Inc., as well as the Corporate Research Lab of Invitrogen (Thermo Fisher Scientific). He is experienced with molecular and immunological test systems and specializes in pharmacogenomics studies. He has an extensive publication record, makes public speaking appearances and supports client submissions to the FDA.
Dr. Kolman received his Ph.D. in molecular Biophysics and Biochemistry from Yale University, specializing in molecular virology and is an alumnus of the University of Illinois.
John L. Kolman, PhD, Joins BioReliance Corp. As Senior Director, Research and Development Baltimore
www.citybizlist.com, 22 April 2008 [cached]
John L. Kolman, PhD, Joins BioReliance Corp.As Senior Director, Research and Development
Description:ROCKVILLE, Md.--(BUSINESS WIRE)--BioReliance Corporation announced today that John Ludwig Kolman, PhD, has been named Senior Director, Research and Development.He reports to Vice President and Chief Scientific Officer (CSO) David Onions, PhD.
BioReliance Corporation is a leading contract services company that provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services to the pharmaceutical and biopharmaceutical industries worldwide.
Dr. Kolman was previously with Invitrogen Corporation (NASDAQ: IVGN) as the Principal Scientist on the HLA Single Antigen Initiative and Lung Cancer Biomarker Programs.Before that he conducted research at the Salk Institute, La Jolla, California, focusing on DNA replication initiation.He is co-inventor of a method to detect multiple antigens (patent pending) and widely published.
After earning an undergraduate degree cum laude with majors in Honors Biology and Chemistry from University of Illinois, Dr. Kolman earned a Master's degree and PhD in Molecular Biophysics and Biochemistry from Yale University.
"I am delighted that John has joined BioReliance as Senior Director of R&D," said Dr. Onions."He has a tremendous record of achievement in research both in the academic setting and in industry.His appointment, plus our investment in new R&D laboratories, signal a new era in this company's history and reflects our commitment to the development innovative products and services for our customers."
"BioReliance has become a highly dynamic organization, entering a high growth phase based on accelerated and strategic R&D," said Dr. Kolman.
QPS Announces John ...
www.qps.com, 1 Nov 2014 [cached]
QPS Announces John Kolman as Executive Director and Head of Translational Medicine - November, 2014 QPS Announces John Kolman as Executive Director and Head of Translational Medicine QPS Logo
...
QPS Announces John Kolman as Executive Director and Head of Translational Medicine - November, 2014 The Big Picture: Why We Do What We Do - Antibody-Drug Conjugates (ADCs) in Action - November, 2014
...
QPS Announces John Kolman as Executive Director and Head of Translational Medicine
(Newark, DE; November 24, 2014) - QPS Holdings, LLC, a leading full-service contract research organization, has named John Kolman, M.Phil., Ph.D. as Executive Director and Head of Translational Medicine. John Kolman will work with QPS' Strategic Leadership Team to assist clients in quickly moving their drug candidates from pre-clinical through late stage development by employing diagnostic testing that allows the selection of appropriate and optimal drug therapies based on a patient's DNA, RNA, and/or protein pathophysiology.
"After many years of successful leadership by LingSing Chen, who recently retired after serving as Vice President and Global Head of Translational Medicine and Biosimilars, it is my pleasure to announce the hiring of John Kolman as her successor," said Ben Chien, PhD, QPS President and CEO.
...
"In his new position, John will be heading up our translational medicine division while serving our clients as an expert in biomarker research & development. As an effective business executive and innovative life scientist whose broad expertise includes all areas pertinent to translational and individualized medicine, John will be a major asset in this exciting and extremely important role, so crucial to our future success in helping clients develop personalized drug therapies."
Kolman comes to QPS after over 20 years in the pharmaceutical R&D industry, having held multiple leadership roles. He is also well known throughout the industry for his scientific leadership, as evidenced by recent speaking engagements at fora such as the World PGx (Pharmacogenomics) Summit (San Francisco), the International Conference on Biomarkers and Clinical Research (Philadelphia), and the PDA/FDA (Parenteral Drug Association/Food and Drug Administration) Advanced Technologies for Virus Detection in Biologicals Conference (Bethesda). Kolman received his Ph.D. in Molecular Biophysics and Biochemistry from Yale University and his published works have appeared in such noteworthy periodicals as Science and Biologicals, and are pending with Applied Microbiology and Biotechnology, the Journal of Pharmaceutical Science and Technology, BioProcessing Journal, and in the PDA Press. His experience in biomarkers, biologics, pharmacogenomics, genetics, and bioinformatics has earned him recognition as an expert in these fields.
Other People with the name "Kolman":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304